FDMT
4d Molecular Therapeutics
$11.03
+$0.23 (+2.13%)Oct 26, 2026
Key metrics
The numbers that frame FDMT today
- Market cap
- $609.34M
- Gross margin
- 100%
- EV / Sales
- 6.3
- ROIC
- -42.8%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $6.96
- 52wk High
- $16.91
Growth
Revenue and earnings trend for FDMT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about FDMT
Is 4d Molecular Therapeutics a good buy?
Hold. 4d Molecular Therapeutics has excellent momentum, but weak quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think 4d Molecular Therapeutics is selling at a very high price.
What is the market capitalization of FDMT?
4d Molecular Therapeutics's market capitalization is $609.34M.
What is the 52-week high for FDMT stock?
The 52-week high for 4d Molecular Therapeutics is $16.91. The current close of $11.03 is 34.8% below that high.
What is the 52-week low for FDMT stock?
The 52-week low for 4d Molecular Therapeutics is $6.96. The current close of $11.03 is 58.5% above that low.
Does FDMT stock pay dividends?
4d Molecular Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for FDMT?
4d Molecular Therapeutics's Debt / Equity ratio is 0.1.